Navigation Links
Technology Implications of Sarbanes-Oxley

Corporate America is currently facing major government-mandated change as a result of the Sarbanes-Oxley Act (Sarbox). While the act requires near real-time reporting and companies to continually evaluate their financial controls and regulatory compliance, it is not explicit as to the technology requirements and information technology (IT) solutions. In fact, Sarbox does not mandate any technology......

Full article >>> sections of Sarbox have implications for content, document and processes technologies. Section 302 explicitly puts the accountability burden on chief executives with hefty fines and criminal ramifications for material financial misstatements. Section 404 requires companies to document financial reporting controls in great detail and create a system to monitor and test effectiveness. If manageme......

Full article >>> Reporting Language) is likely to become the standard in facilitating content integration.

Enforce a standard approach to documentation and workflow to ensure accuracy of information and continuity across the organization.

Establish a central repository for data. Data must be easily accessible and fully searchable by executives and auditors.

User cooperation is vital......

Full article >>>
'"/>

Source:wistechnology.com By Ronald Kral 01/28/04


Related biology technology :

1. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
2. Enhancing Ruggedness and Full-Scan MS Sensitivity Using Ion Sweep Technology
3. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
4. Use of FlashPlate Technology for In Vitro Measurement of [35S]-GTPγS Binding in CHO Cells Expressing the Human 5-HT1B Receptor
5. Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors
6. Use of FlashPlate Technology for In Vitro Measurement of 125I-Labeled TGF-1 Binding on Chimeric Extracellular Domain of Type II Transforming Growth Factor Receptor
7. DNA purification from pig ears to bird blood using proven DNeasy Technology
8. Near Infrared Technology and Optical Agents For Molecular Imaging
9. Technology helps but the best way to reduce Sarbox cost is with people
10. Hutchinson Technology to lay off 165 in Eau Claire
11. Technology and mergers: Getting the strategic applications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... SHANGHAI , CAMBRIDGE, Mass. and ... --  WuXi NextCODE , a WuXi AppTec group ... today announced that the company,s chief operating officer Hannes Smarason ... WuXi AppTec senior vice presidents John Long and ... and chief operating officer, respectively. "WuXi NextCODE ...
(Date:2/28/2017)... 28, 2017 WuXi AppTec, a leading ... and technology platform company, today announced that its ... Shanghai once again passed US FDA,s ... The inspectors from FDA thoroughly audited WuXi,s ... scientific data integrity, operation infrastructure, equipment, sample storage, ...
(Date:2/28/2017)... (PRWEB) , ... February 28, 2017 , ... ... trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial Travel and ... 15 years of meeting this unique need within the biotechnology and pharmaceutical industries ...
(Date:2/28/2017)... PA (PRWEB) , ... February 28, 2017 , ... Over ... them children. In a new educational webinar on March 7, DrugDev will ... professionals working in this especially difficult area. , Webinar: Overcoming the Challenges of ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):